E3 Breast Cancer Taxotere Combination

Clinical trial NCT00494481 · COMPLETED

Trial details

NCT number: NCT00494481
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2006-01-01
Primary completion: 2007-06-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.